By Kyle Morris


Creo Medical Group PLC said Monday that it has signed a long-term, multiyear collaboration agreement for the use of its technology with Intuitive Surgical Inc.'s robot-assisted surgical platform.

The London-listed medical-device company said that the collaboration provides a framework for joint clinical studies and includes milestone payments and royalty structures for any products which may be sold in the future.

Shares in Creo at 0822 GMT were up 2.00 pence, or 2.1%, at 98.00 pence.


Write to Kyle Morris at kyle.morris@dowjones.com


(END) Dow Jones Newswires

05-23-22 0446ET